Neurological Disorders Showing Rapid Growth Worldwide
The BRICS deep brain stimulation (DBS) devices market is expanding as neurological disorders such as Parkinson's disease, epilepsy, dystonia, essential tremor, and treatment-resistant psychiatric conditions continue to rise across Brazil, Russia, India, China, and South Africa. Rapid urbanization, longer life expectancy, and increasing survival rates for chronic diseases are contributing to a larger patient population requiring long-term neurological care. In countries like China and India, growing aging populations are particularly increasing the number of Parkinson's disease cases, placing pressure on neurology services in major urban hospitals.
Healthcare infrastructure development across BRICS nations is improving diagnostic capabilities, leading to earlier and more accurate identification of movement disorders. In China, expanding neurology departments in tier-1 and tier-2 cities such as Beijing, Shanghai, and Guangzhou are enabling more consistent detection of DBS-eligible patients. Similarly, in Brazil and South Africa, private hospital networks are increasingly managing advanced neurological cases, where patients with severe motor fluctuations are being referred for surgical intervention when medication therapy becomes insufficient.
However, access to advanced neuromodulation therapies remains uneven across BRICS countries due to disparities in healthcare funding and specialist availability. While urban centers in Russia and China offer relatively advanced functional neurosurgery services, rural regions across India and Brazil still face delays in diagnosis and referral. Despite these limitations, growing awareness among neurologists and increasing patient advocacy are gradually supporting wider consideration of DBS as a viable treatment option for advanced neurological disorders.
Next-Generation Closed-Loop and Adaptive DBS Systems
Innovations in technology have been instrumental in influencing the growth of the market for BRICS DBS devices through their implementation in closed-loop and adaptive stimulation techniques. Such high-end DBS systems are able to vary the electrical stimulation in response to the brain activity, making the process more precise for the treatment of illnesses like Parkinson's. This factor proves important when considering that in BRICS nations there is a variety of disease progression and continuous medical supervision might be difficult to obtain.
China is emerging as a major hub for neuromodulation innovation within the BRICS group, with increasing integration of AI-driven programming tools and domestically developed DBS systems in leading hospitals. In India, leading neurology centers in cities like Mumbai, Delhi, and Bengaluru are gradually adopting next-generation DBS technologies, supported by expanding private healthcare investments. Meanwhile, Brazil and South Africa are witnessing early-stage introduction of rechargeable and directional DBS systems in specialized neurosurgical centers.
In addition, international collaborations and technology transfer agreements are accelerating exposure to adaptive DBS technologies across BRICS nations. Russia is increasingly participating in neurotechnology research initiatives that explore brain-computer interface integration with stimulation systems. As healthcare infrastructure modernizes and more neurosurgeons receive specialized training, the adoption of closed-loop DBS systems is expected to grow, enabling more personalized and efficient treatment approaches for complex neurological disorders across the BRICS region.
